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Review Article
MAGNETIC RESONANCE IMAGING IN THE STAGING OF CERVICAL
CANCER*
Claudia C. Camisão1, Sylvia M.F. Brenna2, Karen V.P. Lombardelli3, Maria Célia R. Djahjah4,
Luiz Carlos Zeferino5
Cervical cancer is the worldwide leading cause of cancer-related death of women, especially in developing
countries. The International Federation of Gynecology and Obstetrics recommends staging during surgery,
however, surgical-pathologic staging would not be feasible in cases of more advanced cancers. Generally,
in these cases, the staging is performed by means of clinical and gynecological examination and basic imag-
ing studies. However, such an approach fails to demonstrate the actual extent of the disease, and does not
include significant prognostic factors such as tumor volume, stromal invasion and lymph node involvement.
Magnetic resonance imaging has increasingly been utilized in cervical cancer staging, since at early stages
of the disease its performance may be compared to intraoperative findings and, at advanced stages, it shows
to be superior to the clinical evaluation. Additionally, magnetic resonance imaging presents an excellent imaging
resolution for the different densities of pelvic structures, does not require ionizing radiation, is comfortable
for the patient, improves de staging, allowing the early detection of recurrence and the identification of re-
liable prognostic factors which contribute to the therapeutic decision making process and results prediction
with an excellent cost-effectiveness. The present article is aimed at reviewing the most significant aspects
of magnetic resonance imaging in the cervical cancer staging.
Keywords: Cervical cancer; Staging; Magnetic resonance imaging.
Ressonância magnética no estadiamento dos tumores de colo uterino.
O câncer de colo uterino é a maior causa de morte entre mulheres em todo o mundo, notadamente nos
países em desenvolvimento. A Federação Internacional de Ginecologia e Obstetrícia preconiza o estadiamento
durante o ato operatório, porém nos casos mais avançados a abordagem terapêutica não é cirúrgica. Nestes
casos, o estadiamento, em geral, é feito com o exame clínico ginecológico e exames básicos de imagem.
Entretanto, essa forma de abordagem não expressa a real extensão da doença e não inclui importantes fa-
tores prognósticos como volume tumoral, invasão estromal e acometimento linfonodal. A ressonância mag-
nética está sendo cada vez mais utilizada para este fim, pois nos estádios iniciais seu desempenho pode ser
comparado aos achados intra-operatórios e nos estádios avançados se mostra superior em relação à avaliação
clínica. A ressonância magnética apresenta excelente resolução para diversas densidades das estruturas
pélvicas, não utiliza radiação ionizante, é confortável, melhora o estadiamento, permite a detecção precoce
de recidiva e a identificação de fatores prognósticos fidedignos que contribuem na decisão e predição dos
resultados terapêuticos, com excelente custo-efetividade. Este artigo tem como objetivo revisar os aspectos
da ressonância magnética mais importantes no estadiamento desta doença.
Unitermos: Câncer de colo uterino; Estadiamento; Ressonância magnética.
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INTRODUCTION
Presently, uterine cervix carcinoma rep-
resents a significant public health problem.
Despite the longer survival of patients be-
cause of earlier diagnoses and more effec-
tive therapies, this disease still remains as
the leading cause of cancer-related death of
women in the majority of developing coun-
tries(1). Cervical carcinoma is a slow-grow-
ing disease, usually invading the vagina
and the paracervical space along the
parametrium and uterosacral ligaments.
Also, bladder, rectum, pelvic and paraaortic
lymph nodes may be invaded(2). The pattern
of pelvic dissemination of cervical carci-
noma restricts the utilization of surgical
treatment for early stages of the disease,
given the lack of a safety margin in the re-
section of tumors which may have already
affected the paracervical space.
The staging recommended by Interna-
tional Federation of Gynecology and Ob-
stetrics (FIGO) is widely adopted both for
therapy planning and post-therapy follow-
up, however it has shown to be inaccurate
in the estimation of the actual tumor extent.
Additionally, the FIGO staging system does
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not take into consideration relevant prog-
nostic factors such as the tumor volume,
vascularization, endophytic or exophytic
growth, stromal invasion and lymph nodes
involvement(3,4). Considering this flaw, the
FIGO Committee on Gynecologic Oncol-
ogy started recommending that the definite
staging is based on the surgeon’s and
pathologist´s intraoperative findings (Fig-
ure 1)(5).
In cases where cervical carcinoma is
locally advanced (above IIb), the majority
of specialized centers have opted for exclu-
sive radiotherapy or radiotherapy in asso-
ciation with chemotherapy. Therefore, the
clinical finding that could not be intraop-
eratively confirmed should be based pre-
dominantly on highly accurate studies.
However, in developing countries, basic
imaging equipment is not always widely
available in health services; so the gyneco-
logical examination ends up being the main
alternative for staging of cervical carcino-
mas. The involvement of the parametrium
evaluated by rectal examination is a param-
eter which frequently characterizes a lo-
cally advanced carcinoma(6). Mistakes may
occur, especially due to underestimation of
the disease extent as a consequence of limi-
tations of the clinical-gynecological exami-
nation(7).
MAGNETIC RESONANCE IMAGING
Magnetic resonance imaging (MRI) can
evaluate the actual extent of the disease
because of its high spatial and contrast
resolution for pelvic tissues and organs.
Some advantages of MRI are short acqui-
sition time with multiplanar images, com-
fort for the patient, absence of ionizing ra-
diation, and, mainly, the high reproducibil-
ity in the evaluation of musculotendinous
structures in the pelvis which are of great
relevance in the parametrium evaluation(8).
T2-weighted images provide excellent
details of the cervical anatomy and normal
uterus, besides identifying the primary tu-
mor and its extent. The normal cervical
stroma presents a low density signal on this
sequence, and about 95% of tumors of uter-
ine cervix appear as slightly hyperintense
masses in relation to the surrounding
stroma(9) (Figure 2). Pre-invasive lesions of
uterine cervix carcinoma cannot be identi-
fied on T2-weighted images, but may be
described as an area of marked early im-
pregnation in the arterial phase of MRI
dynamic studies(10).
Prognostic parameters influencing in an
appropriate therapy choice, and which may
be evaluated by means of gynecological
examination, can be evaluated by MRI with
a good cost-effectiveness ratio, considering
that patients with cervical cancer submit-
ted to MRI as the initial staging method,
require less tests or procedures in compari-
son with those submitted to a traditional
staging method(11,12).
As a matter of fact, MRI has shown a
better accuracy than the clinical examina-
tion and computed tomography (CT) as
staging methods, particularly in the para-
metrial evaluation. Comparative studies of
the three methods (MRI, CT and clinical
examination) have demonstrated 92% ac-
curacy for MRI compared with 78% for
clinical examination, and 70% for CT(13).
With the arrival of new turbo sequences
and phased-array coils, sensitivity reported
for parametrial invasion was 100%(14).
Other authors highlight a 98% negative
predictive value for parametrial invasion in
T2-weighted turbo spin-echo (TSE) and
short tau inversion recovery (STIR) se-
quences(15,16).
The correlation between uterine cervix
carcinoma staging proposed by FIGO and
MRI findings is described in Table 1(17)
.
Examination technique
MRI for staging of uterine cervix tu-
mors should cover from the plane passing
Figure 1. Staging of uterine cervix carcinoma according to FIGO(3).
≤ 4 cm > 4 cm
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The staging of uterine cervix tumors
requires three planes in the T2-weighted
TSE sequence in high resolution, i.e., 512
matrix, small field-of-view (FOV), sections
always < 5 mm (preferably 3–4 mm), with
gap of zero, all of them obtained in the axial
plane. Additionally, a T1-weighted TSE se-
quence in the true axial plane of the pelvis
with large FOV is essential for acquisition
of a global pelvic view(17).
Sagittal images are useful for demon-
strating the relation between tumor and
cervix, uterine body, vagina and adjacent
organs such as bladder and rectum. On the
other hand, axial images are relevant for
detection of parametrial and pelvic wall
invasion, ureteral and lymph nodes in-
volvement. The coronal plane, in conjunc-
tion with the sagittal and axial planes, is
useful in the parametrial evaluation, and
particularly necessary for measurement of
the tumor volume (Figure 3).
T2-weighted TSE is the sequence of
choice in the evaluation of lymph nodes
involvement, since in this sequence,
muscles and vessels appear hyperintense,
differently from lymph nodes. Fat suppres-
sion improves even more the identification
of structures or lesions surrounded by adi-
pose tissues like parametrium and lymph
nodes(15,20) (Figure 4).
Many times, the use of contrast is not
necessary in the staging, since, in most of
cases, precontrast sequences provide the
necessary information. Besides, dynamic
sequences frequently underestimate the
tumor volume and the depth of the stromal
invasion, and should not be utilized for
these purposes(21). However, the use of
contrast agent may be useful for facilitat-
ing the identification of fistulous tracts in
advanced diseases or in the post-therapy
follow-up(10).
TUMOR GROWTH PATTERNS
The tumor arises in the cervical canal
and extends peripherally towards the cer-
vical stroma, progressively replacing it. A
full-thickness stromal invasion may occur,
and, by contiguity, a parametrial invasion
(IIb). Cervical canal obstruction is usual,
and frequently causes the endometrial cav-
ity to be distended with blood, serous fluid
or purulent material(22) (Figure 5).
Table 1 Correlation between FIGO staging of uterine cervix cancer and MRI findings(17).
Ia
Ib
Ib1
Ib2
IIa
IIb
IIIa
IIIb
IVa
IVb
Stage MRI T2-weighted sequence
Microinvasor
Invasive, confined to the cervix
Clinically visible lesion ≤ 4 cm
Clinically visible lesion > 4 cm
Tumor invades the upper vaginal third,
but does not affect the lower vaginal third
Tumor invades the parametrium, but not
the pelvic wall neither the lower vaginal
third
Involvement of the lower vaginal third,
without affecting the pelvic wall
Pelvic wall involvement or hydronefrosis
Tumor invades the bladder or rectum
mucosa
Distant metastasis
No tumor evidence
Hyperintense tumor on T2-weighted sequence in
contrast with hypointense signal from cervical stro-
ma
Tumor partially or completely replacing the hypo-
intense cervical stroma, not surpassing the para-
metrial interface represented by a hypointense halo
Segmental interruption of hypointense signal on
the upper third of the vaginal wall
Hyperintense tumor interrupting hypointense halo
of the interface between cervical stroma and pa-
rametrium
Segmental interruption of the hypointense signal
of the lower vaginal third
Tumor extending to the musculature (internal ob-
turator muscle, piriform muscle or levator ani mus-
cle) or causing hydroureter
Loss of hypointense signal of the internal wall (mu-
cosa) of the bladder or rectum
Distant metastasis
Figure 2. A: Sagittal T2-weighted TSE sequence, hyperintense uterine cervix tumor. Part of the
(hypointense) cervical stroma is intact. Preserved vaginal canal (stage Ib). B: Sagittal T2-weighted TSE
sequence, slightly hyperintense tumor in the posterior portion of the uterine cervix, extending to the upper
vaginal third (stage IIa).
A B
〈
〈〈〈〈
through the inferior renal pole to the vulva,
including the paraaortic and pelvic regions.
The anterior saturation band should be uti-
lized as a routine to reduce respiratory and
peristaltic artifacts. On the other hand, the
posterior saturation band is dispensable.
The use of antiperistaltic agents four to six
hours before the examination also is rec-
ommended to reduce artifacts resulting
from intestinal peristalsis(3,10). The phased-
array coil improves the signal-noise ratio,
allowing the acquisition of more detailed
images than the formerly utilized body
coils, and, consequently improving the
imaging resolution. However, body coils
may be useful for obese patients with a very
protuberant abdomen, or for retroperitoneal
evaluation(18). The utilization of endorectal
and endovaginal coils has been described
as means to produce high-signal images,
but, despite the high degree of definition,
their use is limited because of the lack of
consensus about their advantages over the
phased-array coils(19).
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Figure 4. A: Axial T2-weighted TSE sequence, the same patient in Figure 3 in an uppermost plane. The arrows indicate bilateral adenomegalies, with a slightly
hyperintense signal similar to the cervical tumor. B: Axial T2-weighted TSE sequence with fat suppression. The arrows indicate the same adenomegalies as a,
more evident in this sequence.
A B
〈〈〈〈 〈
Tumors extending into the uterine cav-
ity are associated with a worst prognosis
and higher prevalence of distant me-
tastases(2). Clinically, tumors with endo-
phytic growth are difficult to be measured,
since the largest component cannot be di-
rectly visualized and evaluated in a gyne-
cological examination. The clinical evalu-
ation of exophytic tumors is easier, but
MRI facilitates the identification of a pos-
sible vaginal invasion.
Evaluation of parametrium and pelvic
wall
The parametrium is the connective tis-
sue between the layers of the broad liga-
ment. Medially it is contiguous with the
uterus, cervix and proximal vagina; extend-
ing laterally to the pelvic wall. Inferiorly,
it is nearly the cardinal ligament. It is pre-
dominantly consisted of fat through which
run uterine vessels, nerves and lymphatic
vessels(11).
Parametrial invasion (above IIb) is a
significant prognostic factor influencing in
the diagnosis and therapeutic choice. On
T2-weighted sequences, the interface be-
tween the normal cervical stroma and the
parametrium appears like a hypointense
ring or halo surrounding the cervix. A pre-
served hypointense halo represents a high
negative predictive value for parametrial
invasion(15,17). The indicator of parametrial
invasion is the segmental interruption or
complete absence of this halo in the inter-
face between the cervical stroma and the
parametrial fat, or yet, the clear protrusion
of the tumor into the parametrium(13,23).
Some authors correlate the complete re-
placement of the cervical stroma and the
tumor extension into the uterine body with
the parametrial invasion. In these cases,
94% of the parametrium is invaded, with
direct relation between the size of the tu-
mor and the parametrial involvement(15,22).
Loss of parametrial fat may be an indica-
tor of invasion, but this is a non-specific
sign, since peritumoral inflammation also
Figure 3. A: Axial T2-weighted TSE sequence, tumor completely replacing the cervical stroma in its largest anteroposterior diameter. B: Coronal T2-weighted
TSE sequence of the same patient showing the largest latero-lateral diameter of the tumor. Note the bilateral adenomegalies. C: Sagittal T2-weighted TSE
sequence, largest craniocaudal diameter of the tumor. Preserved signal of the bladder mucosa.
A B C
7,25 cm
4,45 cm
7,13 cm
211
MR imaging in the staging of cervical cancer
Radiol Bras 2007;40(3):207–215
Figure 5. A: Sagittal T2-weighted
TSE sequence, hyperintense tu-
mor completely replacing the
uterine cervix stroma and ob-
structing the cervical canal, caus-
ing distension of the endometrial
cavity filled with a highly hyper-
intense fluid. B: Sagittal T2-
weighted TSE sequence, tumor
completely replacing the uterine
cervix stroma; so there is no ac-
cumulation of fluid inside the
endometrial cavity.
A B
may result in loss of fat simulating inva-
sion.
Contrast-enhanced T1-weighted se-
quences have demonstrated higher accu-
racy than the T2-weighted in parametrial
evaluation(10) (Figure 6). In cases where the
tumor extends into the parametrium it may
reach the ureter, causing hydronephrosis
(IIIb). Hydronephrosis associated with
mass in the uterine cervix are specific signs
of parametrial invasion(12).
Parametrial invasion up to the pelvic
wall (IIIb) is diagnosed when the tumor
cannot be separated from the pelvic wall at
clinical examination. At MRI, this diagno-
sis is made when the distance between the
tumor and the pelvic wall is < 3 mm, or
when T2-weighted sequences show partial
or complete loss of a normal hyposignal of
the pelvic wall musculature (piriform
muscle, internal obturator muscle, levator
ani muscle or coccygeal muscle) (Figure 7).
In these cases, iliac vessels become com-
pressed and narrowed by the tumor, and the
bone destruction may occur by direct exten-
sion of a diffusely infiltrated tumor(25).
Vaginal involvement
MRI is highly sensitive in the detection
of vaginal invasion, with 93% accuracy(11).
The sign of vaginal involvement is better
characterized on high-resolution T2-
weighted sequences, showing the segmen-
tal interruption of the normal hypointense
signal of the vaginal wall, or yet a hyperin-
tense vaginal thickening (tumor), or the
mass itself in contiguity with the vaginal
wall (Figure 8). Vaginal invasion corre-
sponds to stage IIa; when this invasion
extends up to the lower vaginal third, cor-
responds to stage IIIa(25). Additionally, the
use of intravaginal ultrasonographic gel
during the MRI acquisition is recom-
mended to distend and fill the cavity with
a highly hyperintense material on T2-
haematocolpos
cervical canal
Figure 6. A: Coronal T2-weighted TSE sequence showing bilateral parametrial invasion, loss of hypointense halo separating the interface between the cervical
stroma and the parametrial fat. Note the fimbrias laterally along the parametrium which also represent indirect signs of parametrial invasion (stage IIb). B: Axial
T1-weighted sequence with fat suppression of the same patients, showing the bilateral involvement of uterosacral involvement.
A B
 
tumor
bladder
uterosacral
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Figure 7. A: Axial illustration of the pelvis showing a tumor restricted to the cervix, with no sign of parametrial invasion (stage I). B: Axial illustration of the pelvis
showing a tumor invading the parametrium, without reaching the pelvic wall or right ureter (stage IIb). C: Axial illustration showing cervical tumor invading the
parametrium and reaching the right ureter (stage IIIb). D: Axial illustration showing cervical tumor invading the parametrium and reaching the pelvic wall (stage
IIIb). E: Axial T2-weighted TSE sequence showing a cervical tumor involving the urethra, and extending up to the pelvic wall with alteration of the ischium signal
(arrow). F: An uppermost image of the same sequence clearly showing parametrial invasion (arrow).
sequences). This procedure improves the
sensitivity in the evaluation of the vaginal
invasion. About 20 ml of gel applied at the
moment of the examination are sufficient(10).
Lymph node involvement
Several studies have demonstrated the
significance of the lymph node involve-
ment as a factor of worsening in the sur-
vival prognosis of women affected by uter-
ine cervix tumor(3,26). There are three drain-
age routes from the cervical lymph nodes
through which the tumor propagates (Fig-
ure 9): the lateral route, along the external
iliac vessels; the hypogastric route, along
the internal iliac vessels; and the presacral
route, along the uterosacral ligament. All of
the three routes drain into the common iliac
lymph nodes, through which the tumor may
reach the paraaortic lymph nodes. Gener-
ally, the paracervical and parametrial lymph
nodes are the first to be affected, followed
by the obturator lymph nodes and, subse-
quently, the external and internal iliac
lymph nodes(27).
weighted sequences in order to improve the
tumor contrast (slightly hyperintense on
T2-weighted sequences) and the vaginal
wall contrast ((hypointense on T2-weighted
Figure 8. Sagittal T2-weighted TSE sequence
showing uterine cervix tumor invading the upper
vaginal third. Observe that the introduction of the
intravaginal ultrasonographic gel (highly hyperin-
tense on T2-weighted sequences) distends the
vaginal wall and improves de assessment of the
invasion.
T2-weighted are the sequences of
choice for evaluation of pelvic lymph
nodes, since in these sequences vessels and
musculature become hypointense, facilitat-
ing the differentiation from lymph nodes
which are slightly hyperintense on T2-
weighted sequences (Figure 10). T2-
weighted TSE fat suppressed sequences
allow the suppression of the adipose tissue
surrounding the lymphatic vessels, improv-
ing the accuracy in the detection of pelvic
adenomegalies(12) (Figure 11). Up to the
present moment, the suspicion of lymph
node metastasis by means of MRI is lim-
ited to the increase in the size of the lymph
node. Lymph nodes > 10 mm in axial di-
ameter are considered as abnormal. Also,
some higher limits are suggested for deter-
mined specific sites, as follows: for lymph
nodes in the internal iliac chain, 7 mm; for
common iliac lymph nodes, 9 mm; and for
external iliac lymph nodes, 10 mm.
Positron emission tomography with fluoro-
deoxy-D-glucose (PET-FDG) seems to of-
fer higher specificity than MRI for enlarged
A B C
D E F
tumor
parametrium
bladder
〈
tumor
intravaginal gel
bladder
213
MR imaging in the staging of cervical cancer
Radiol Bras 2007;40(3):207–215
pelvic lymph nodes(3). When lymph node
central necrosis is identified, the positive
predictive value for malignancy is 100%.
It has been already demonstrated that
lymph nodes with necrosis or signal inten-
sity similar to the tumor presented worst
prognosis. The diagnosis of lymph node
necrosis may improve with the use of en-
dovenous contrast (25,28).
Most recently, improvement has been
demonstrated in the MRI sensitivity for
detection of metastatic lymph nodes in uter-
ine cervix tumors, utilizing a new type of
lymph node-specific contrast agent called
ferumoxtran-10, with nanoparticles of iron
oxide (USPIO). However the utilization of
this contrast agent is not a consensus yet(29).
Considering that the FIGO staging system
does not take the lymph nodes involvement
into consideration, the detection of en-
larged pelvic lymph nodes on MRI corre-
sponds to stage IIIb, as well as the diagno-
sis of enlarged paraaortic lymph node cor-
responds to stage IVb(12).
Invasion of bladder and rectum
Invasion of bladder or rectum (IVa) may
be difficult to be detected only by a physi-
cal examination. MRI has shown to be a
reliable method for detection of bladder
invasion with 83% sensitivity, specificity
near 100%, and 99% accuracy. When the
bladder presents invaded by the tumor, its
wall, which normally is hypointense,
shows a focal or diffuse area with increase
in the signal intensity on T2-weighted se-
quences, or simply a vegetating mass into
the lumen is observed(10,30). For defining
the bladder invasion, it is important to ob-
serve that signal alteration is present both
for the bladder muscle and mucosa, other-
wise the tumor may be just contiguous to
the bladder(4). Other indicative signs of
invasion are hyperintensity on the internal
surface of the posterior wall, nodularity or
irregularity in the bladder wall (Figure 12).
On the other hand, the vesico-ureteral junc-
tion is poorly evaluated because of the dif-
ficult visualization of a non-dilated ureter
on MRI.
Direct invasion of the ureter is not fre-
quent, however, in the setting of ureter in-
vasion, a tumor extension is observed along
the uterosacral ligaments. Findings, usu-
Figure 9. Lymphatic drainage
route of uterine cervix tumor.
Coronal (left) and sagittal (right)
illustrations showing, in black,
primarily affected lymph nodes,
and, in gray, those secondarily
affected.
Figure 10. Coronal T2-weighted TSE sequence
showing uterine cervix tumor and bilaterally en-
larged lymph nodes (arrows).
Figure 11. Axial T2-weighted sequence with fat-suppression on the same plane as Figure 10, showing
enlarged and hyperintense lymph nodes in this sequence.
Common iliac
Common iliac
Internal iliac
External iliac
Parametrial
Inguinal
Sacral
Internal iliac
Obturator
Paracervical
Sacral
Internal iliac
Obturator
Aortic
〈〈〈〈〈
〈tumor
uterus
〈
uterus
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ally, are: focal thickening or segmental in-
terruption of the hypointense signal on the
anterior rectal wall(10).
FINAL CONSIDERATIONS
Even though MRI is not utilized by the
majority of oncology services for staging
uterine cervix tumors, and, up to this mo-
ment, it has not been officially approved by
FIGO yet, it is the best imaging method in
terms of accuracy for assessment of tumors,
and plays an essential role in the therapeu-
tic planning and follow-up(31).
MRI has shown to be better than the
clinical examination, and, when utilized as
the initial staging method, reduces the
number of invasive procedures and radio-
logical studies such as urography, cytoscopy
and rectosigmoidoscopy, with lower cost
for the management of the disease. Addi-
tionally, the correct assessment of the tu-
mor extent and volume allows optimizing
the planning of the fields for external pel-
vic radiotherapy and brachytherapy.
A recent study has demonstrated that the
MRI-aided radiotherapy planning may re-
duce the possibility of geographic errors as
compared with the conventional radio-
therapy planning(32). It is important that the
radiologist interpreting a pelvic MRI for
uterine cervix tumor, is familiarized with
the findings and, mainly, provides informa-
tion regarding tumor volume, invasion of
parametrium, vagina and adjacent organs,
besides indicating the tumor growth type
and lymph nodes involvement.
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